![Jacob Borrajo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jacob Borrajo has founded Coral Genomics, Inc. in 2018 and Amber Bio, Inc. in 2021.
Mr. Borrajo is the founder of Amber Bio, Inc. and holds the title of Chief Executive Officer.
| Unternehmen | Position | Beginn |
|---|---|---|
Amber Bio, Inc.
 Amber Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in biotechnology and pharmaceuticals business | Vorstandsvorsitzender | 01.08.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
Coral Genomics, Inc.
 Coral Genomics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that optimizes drug development and deployment by utilizing genomic data from patients | Gründer | 01.09.2021 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Coral Genomics, Inc.
Coral Genomics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that optimizes drug development and deployment by utilizing genomic data from patients | Health Technology |
Amber Bio, Inc.
Amber Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in biotechnology and pharmaceuticals business | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
